L3750
β-乳糖
≤30% α-anomer basis, ≥99% total lactose basis
别名:
β-D-Gal-(1→4)-β-D-Glc
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H22O11
化学文摘社编号:
分子量:
342.30
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352201
EC Number:
227-751-9
MDL number:
产品名称
β-乳糖, ≤30% α-anomer basis, ≥99% total lactose basis
InChI key
GUBGYTABKSRVRQ-DCSYEGIMSA-N
InChI
1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11-,12+/m1/s1
SMILES string
OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O
biological source
bovine milk
assay
≥99% total lactose basis
form
powder
concentration
≥30% (α-anomer)
color
white to off-white
solubility
water: 50 mg/mL, clear, colorless
storage temp.
room temp
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
β-乳糖已用于:
- 处理HL-1 细胞，然后进行二丁酸佛波酯 （PDB）处理 ，以研究蛋白激酶 C（PKC）刺激的积累是否通过半乳糖凝集素 3 介导
- 作为培养基的成分用于分析蛋白质的细胞外生成
- 与重组半乳凝集素-3 一起处理细胞以检测半乳凝集素-3的细胞表面结合
- 与重组半乳糖凝集素 3 或对照蛋白一起刺激 T 细胞进行细胞凋亡测定
Biochem/physiol Actions
β-乳糖是化合物乳糖的 β-吡喃糖形式。
乳糖是多种药物的赋形剂，可用作多种食品的添加剂。由于其质地、风味和粘合特性，它被用作食品工业中的商业添加剂
General description
乳糖是人类营养、烹饪制品和药物中的重要二糖。β-乳糖是一种异构形式，在自然界中很少见。
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
A tool for monitoring Trichoderma harzianum: I. Transformation with the GUS gene by protoplast technology
Thrane C, et al.
Phytopathology, 85(11), 1428-1435 (1995)
Benjamin D Grant et al.
Analytical chemistry, 92(16), 11305-11309 (2020-07-02)
The SARS-CoV-2 pandemic has created an unprecedented need for rapid diagnostic testing to enable the efficient treatment and mitigation of COVID-19. The primary diagnostic tool currently employed is reverse transcription polymerase chain reaction (RT-PCR), which can have good sensitivity and
Preparation and characterization of high purity anhydrous beta-Lactose from alpha-Lactose monohydrate at mild temperature
Lopez-Pablos AL, et al.
International Journal of Polymer Science (2018)
Detlef Ritter et al.
Toxicology in vitro : an international journal published in association with BIBRA, 63, 104714-104714 (2019-11-11)
Due to the increasing need of new treatment options against bacterial lung infections, novel antimicrobial peptides (AMPs) are under development. Local bioavailability and less systemic exposure lead to the inhalation route of administration. Combining AMPs with nanocarriers (NCs) into nanosystems
Logan K Smith et al.
eLife, 10 (2021-08-10)
Despite the mechanisms of central and peripheral tolerance, the mature B cell compartment contains cells reactive for self-antigen. How these cells are poised not to respond and the mechanisms that restrain B cell responses to low-affinity endogenous antigens are not
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持